UPDATE : Monday, September 7, 2020
상단여백
HOME Pharma
AstraZeneca Korea elects Kim Sang-pyo as new CEO
  • By Marian Chu
  • Published 2018.02.05 14:47
  • Updated 2018.02.05 15:03
  • comments 0

AstraZeneca Korea said Kim Sang-pyo took office as its new CEO on Monday. Kim had led MSD Korea’s oncology department from 2016 after acquiring more than 10 years of experience in the industry.

AstraZeneca Korea's new CEO Kim Sang-pyo

The Korean branch of AstraZeneca expressed high expectations for Kim, saying that his experience in the field of oncology will help expand the company’s anticancer portfolio.

“Kim’s various experiences and insights will lead AstraZeneca to reach new heights as the company is currently expanding its anticancer drug portfolio,” the company said in a statement.

yjc@docdocdoc.co.kr

<© Korea Biomedical Review, All rights reserved.>

Other articles by Marian Chu
iconMost viewed
  • ‘Cyramza helped improve gastric cancer treatment in Korea’
  • ‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
  • Amgen Korea wins new indication for acute lymphoblastic leukemia drug
  • SNUBH develops AI model predicting patients at risk of cerebral aneurysm
  • Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
    • ‘Cyramza helped improve gastric cancer treatment in Korea’ ‘Cyramza helped improve gastric cancer treatment in Korea’
    Comments 0
    More
    0/300
    Please leave the first comment.
    176 civic groups furious over government-doctors deal176 civic groups furious over government-doctors deal
    여백
    Most viewed
    여백
    Opinion
    [Column] Correct diagnosis leads to proper treatment
    [Column] Correct diagnosis leads to proper treatment
    [Column] How ongoing doctors’ strike is different from 20 years ago
    [Column] How ongoing doctors’ strike is different from 20 years ago
    A Korean-American Doctor asks: Is Korea truly in 2020?
    A Korean-American Doctor asks: Is Korea truly in 2020?
    여백
    Back to Top